Asia is fast becoming a global leader in ADC innovation, with nonstop R&D innovation. As this region continues to unveil first-in-class ADCs, dual payloads, bispecifics, TCE-ADCs, and advanced linkers, its growing role in oncology R&D is quickly gaining global attention, as the focus shifts to clinically validating the next wave of ADC breakthroughs.

In response to this momentum, the 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community.

Join this antibody drug conjugate focused meeting for a comprehensive overview of the evolving ADC landscape in Asia. Explore the latest breakthroughs in R&D, clinical development, and CMC strategies to fast-track your ADC programs. Connect with 60+ expert speakers from industry leaders like AstraZeneca, Daiichi Sankyo, top Asian biotechs, emerging start-ups, and global ADC service providers.

This summit brings together cutting-edge innovators from Asia and the West to advance the future of targeted oncology therapeutics.

Event link here.